Curated Wealth Partners’s Biogen BIIB Stock Holding History

Curated Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.2K	Buy	+26,338	New	+$5.04M	0.01%	684

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Curated Wealth Partners's BIIB Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in Biogen (BIIB) in Q2 2026: 26,338 shares worth $57.2K. The stake represents 0.01% of the portfolio and ranks #684 among its holdings.

328 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Curated Wealth Partners held 26,338 shares of Biogen worth $57.2K as of Q2 2026.
Biogen was a new Curated Wealth Partners position in Q2 2026.
Biogen made up 0.01% of Curated Wealth Partners's portfolio in Q2 2026, its #684 holding.
328 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.